WeedMD (CVE:WMD) had its target price boosted by equities researchers at Eight Capital from C$3.00 to C$3.50 in a report issued on Monday, March 19th. Eight Capital’s target price indicates a potential upside of 133.33% from the company’s previous close.
Shares of WMD opened at C$1.50 on Monday. WeedMD has a 12-month low of C$0.68 and a 12-month high of C$3.25.
TRADEMARK VIOLATION WARNING: This article was first reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this article on another publication, it was illegally copied and reposted in violation of international copyright and trademark legislation. The original version of this article can be read at https://www.thelincolnianonline.com/2018/04/11/eight-capital-boosts-weedmd-wmd-price-target-to-c3-50.html.
WeedMD Company Profile
WeedMD Inc, formerly Aumento Capital V Corp, is a Canada-based company, which supplies a range of cannabis and cannabis-related products. The Company is a licensed producer of medical marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates an approximately 20,000 square foot production facility in Aylmer, Ontario.
Receive News & Ratings for WeedMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WeedMD and related companies with MarketBeat.com's FREE daily email newsletter.